Delivery Order SPE2DB24D1201-SPE2DB24FJANH

Award Date 7/17/24
Potential Completion Date 7/18/24
Potential Value $6.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $7,122.95 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 90-count bottles of Jardiance 10 mg tablets. The order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This...
This is a $15,925.69 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 90-count tablets of the prescription drug Jardiance 10 mg. The contract has an ultimate completion date of August 23, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...
This is a $7,009.21 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for 90 tablets of the prescription medication Jardiance 10 mg. The order has an ultimate completion date of August 7, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical through December 2025 for delivering a wide range of pharmaceuticals...
This is a $6,751.01 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of JARDIANCE 25 MG TABLET 30S, a prescription medication. The order has a completion date of July 26, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999, for providing a wide range of pharmaceutical...
This is a $3,834.86 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Jardiance 25 mg tablets, a prescription medication. The award has no set-aside designation and is expected to be completed by September 4, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a $16,543.79 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Jardiance 25 mg tablets. The order has an ultimate completion date of September 6, 2024 and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for delivering a wide...
This is a $29,979.14 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of JARDIANCE 10 MG TABLET 90S. The order has an ultimate completion date of August 20, 2024. AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of essential medical commodities, including specialty medications, generic drugs, and medical supplies, to support various government...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 90 tablets of the diabetes medication Jardiance 10 mg. The contract has a ceiling value of $3,856.75 and a completion date of October 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a $2,060.28 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 90 tablets of the medication Jardiance 10 mg. The contract has a period of performance through July 19, 2024. AmerisourceBergen is a leading pharmaceutical distributor that provides a wide range of medications and medical supplies to support various government healthcare programs, including for the military and veterans. This delivery order is part of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The $8,781.94 order is for the supply of 90 tablets of the pharmaceutical product Jardiance 10 mg. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug...
  • SPE2DB24D1201
    Indefinite Delivery Contract
  • SPE2DB24D1201-SPE2DB24FJANH
    Delivery Order

This is a $6,758.79 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 90-count packages of the diabetes medication Jardiance 10 mg tablets. The contract has a completion date of July 18, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which serves as the primary vehicle for the company to provide a comprehensive range of medical commodities, including prescription drugs, to support military treatment programs and facilities worldwide. This specific delivery order does not utilize any set-aside designations.

Generated 10/16/24, 9:25 AM